pre-miRNA Information
pre-miRNA hsa-mir-1268a   
Genomic Coordinates chr15: 22225278 - 22225329
Description Homo sapiens miR-1268a stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-1268a
Sequence 5| CGGGCGUGGUGGUGGGGG |22
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs369807489 1 dbSNP
rs537950017 2 dbSNP
rs1442921203 4 dbSNP
rs1242314811 5 dbSNP
rs28599926 6 dbSNP
rs931410682 7 dbSNP
rs1360584039 10 dbSNP
rs1245652939 12 dbSNP
rs1321701831 14 dbSNP
rs1260292644 16 dbSNP
rs879525551 17 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol ITFG3
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions C8166
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3 ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' ggGGGUGGUGGUGCGGGc 5'
            ||: ||:  ::||:| 
Target 5' --CCUUCCG--GUGCUCa 3'
1 - 14
Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM1462572
Method / RBP PAR-CLIP / AGO2
Cell line / Condition C8166 / C8166 NL4-3
Location of target site ENST00000399932.3 | 3UTR | CCUUCCGGUGCUCAC
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
44 hsa-miR-1268a Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT035845 POLR2I RNA polymerase II subunit I 1 1
MIRT035847 FASN fatty acid synthase 1 1
MIRT053736 SOX12 SRY-box 12 1 1
MIRT053737 CAMK2G calcium/calmodulin dependent protein kinase II gamma 1 1
MIRT473717 MAPK1 mitogen-activated protein kinase 1 2 2
MIRT483654 QSOX2 quiescin sulfhydryl oxidase 2 2 4
MIRT484277 AIP aryl hydrocarbon receptor interacting protein 2 4
MIRT486674 WDR81 WD repeat domain 81 2 2
MIRT488672 WWP2 WW domain containing E3 ubiquitin protein ligase 2 2 4
MIRT493453 ITFG3 family with sequence similarity 234 member A 2 2
MIRT495902 ZNF641 zinc finger protein 641 2 2
MIRT500188 BARX1 BARX homeobox 1 2 4
MIRT512015 DNAJC10 DnaJ heat shock protein family (Hsp40) member C10 2 2
MIRT521134 SGPL1 sphingosine-1-phosphate lyase 1 2 4
MIRT530047 TRIM72 tripartite motif containing 72 2 2
MIRT531519 NOM1 nucleolar protein with MIF4G domain 1 2 2
MIRT543736 DHCR7 7-dehydrocholesterol reductase 2 2
MIRT558054 EVI5L ecotropic viral integration site 5 like 2 2
MIRT569603 TRIM29 tripartite motif containing 29 2 2
MIRT570027 FAM228A family with sequence similarity 228 member A 2 2
MIRT573595 CERS1 ceramide synthase 1 2 2
MIRT623884 FRMPD4 FERM and PDZ domain containing 4 2 2
MIRT630000 PDE6B phosphodiesterase 6B 2 2
MIRT632716 MSANTD4 Myb/SANT DNA binding domain containing 4 with coiled-coils 2 2
MIRT633497 ERO1L endoplasmic reticulum oxidoreductase 1 alpha 1 1
MIRT637076 SELPLG selectin P ligand 2 2
MIRT638183 TLN1 talin 1 2 2
MIRT638767 EPB41 erythrocyte membrane protein band 4.1 2 2
MIRT668073 GMPS guanine monophosphate synthase 2 2
MIRT669874 RAET1E retinoic acid early transcript 1E 2 2
MIRT670664 KIAA1551 KIAA1551 2 2
MIRT671283 RPL37A ribosomal protein L37a 2 2
MIRT675055 OR7D2 olfactory receptor family 7 subfamily D member 2 2 2
MIRT682784 BLOC1S3 biogenesis of lysosomal organelles complex 1 subunit 3 2 2
MIRT683344 SCARF1 scavenger receptor class F member 1 2 2
MIRT690283 ZNF154 zinc finger protein 154 2 2
MIRT695172 SLC25A33 solute carrier family 25 member 33 2 2
MIRT695222 SCAMP3 secretory carrier membrane protein 3 2 2
MIRT700485 PTPRF protein tyrosine phosphatase, receptor type F 2 2
MIRT700601 PRKCA protein kinase C alpha 2 2
MIRT701410 NKRF NFKB repressing factor 2 2
MIRT703995 EIF5A2 eukaryotic translation initiation factor 5A2 2 2
MIRT711232 RETSAT retinol saturase 2 2
MIRT719510 TMEM175 transmembrane protein 175 2 2
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-1268a Trastuzumab approved NULL Microarray SKBR3 cells. 22384020 2012 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-miR-1268a Oxaliplatin 6857599 NSC266046 approved sensitive High Colorectal Cancer cell line (HCT-116)
hsa-miR-1268a Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-1268a Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-1268a Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-1268a Imatinib 5291 NSC743414 approved sensitive High Gastrointestinal Stromal Tumor tissue
hsa-miR-1268a Fluorouracil 3385 NSC19893 approved resistant High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-1268a Cisplatin 5460033 NSC119875 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-1268a Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-1268a Fluorouracil 3385 NSC19893 approved sensitive High Pancreatic Cancer cell line (PATU8988)
hsa-miR-1268a Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-1268a Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-1268a Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-1268a Temozolomide 5394 NSC362856 approved sensitive Low Glioblastoma cell line (U87, LN229)
hsa-miR-1268a Trametinib 11707110 NSC758246 approved resistant High Melanoma cell line (M14) (2uM)
hsa-miR-1268a Vemurafenib 42611257 NSC761431 approved resistant High Melanoma cell line (M14) (2uM)
hsa-miR-1268a Cisplatin 5460033 NSC119875 approved resistant Low Tongue Squamous Cell Carcinoma cell line (CAL-27, SCC-9)
hsa-miR-1268a Paclitaxel 36314 NSC125973 approved resistant High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-1268a Paclitaxel 36314 NSC125973 approved sensitive High Breast Cancer cell line (BCap37)
hsa-miR-1268a Doxorubicin 31703 NSC123127 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-miR-1268a Etoposide 36462 NSC141540 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-miR-1268a Vinorelbine 44424639 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-miR-1268a Vincristine 5978 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-miR-1268a Paclitaxel 36314 NSC125973 approved sensitive High Colorectal Cancer cell line (HCT8)
hsa-mir-1268a Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-1268a Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-1268a Cisplatin 5460033 NSC119875 approved resistant cell line (OE19)
hsa-mir-1268a Fluorouracil 3385 NSC19893 approved resistant cell line (OE19)
hsa-mir-1268a Cisplatin 5460033 NSC119875 approved resistant cell line (BxPC3)
hsa-miR-1268a Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-1268a Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-1268a Paclitaxel 36314 NSC125973 approved resistant cell line (BAS)
hsa-miR-1268a Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-1268a Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-1268a Cisplatin 5460033 NSC119875 approved sensitive cell line (MGC-803)
hsa-miR-1268a Pegylated interferon alpha+Ribavirin resistant tissue (chronic hepatitis C)
hsa-miR-1268a Cisplatin 5460033 NSC119875 approved resistant cell line (A549)
hsa-miR-1268a Neoadjuvant chemotherapy sensitive tissue (breast cancer)
hsa-miR-1268a Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-1268a Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide/Methotrexate/Gemcitabine sensitive cell line (Bats-72)
hsa-miR-1268a Cisplatin 5460033 NSC119875 approved resistant cell line (MDAH-2774)

Error report submission